Dr. Robert Jordan Applebaum, MD

Dr. Applebaum practices at Florida Eye Specialists And Cataract Institute in Brandon, Florida.

Dr. Applebaum's NPI, 1700175304, was assigned on April 4, 2011. Dr. Applebaum graduated from University Of Florida College Of Medicine in 2011. Dr. Applebaum holds Florida license ME116761.

Dr. Applebaum's primary practice is Florida Eye Specialists and Cataract Institute, at 403 Vonderburg Dr Suite 101 Suite 101, Brandon, FL 33511-5501. The practice phone is (813) 681-1122.

Dr. Applebaum's primary practice is Florida Eye Specialists And Cataract Institute in Brandon, Florida. Dmand AI also links Dr. Applebaum to 1 medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Applebaum practices. Vendor and product names are available with a free account.

Ophthalmic plastic and reconstructive surgery is Dr. Applebaum's primary specialty in the NPI Registry, under taxonomy code 207WX0200X. Dr. Applebaum is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Applebaum's licenses on file in 2 states: Florida and Virginia.

Dmand AI lists conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation, glaucoma, hereditary corneal conditions, scleritis and secondary membranaous cataract surgery among the conditions Dr. Applebaum treats.

CMS data shows 1,864 Medicare services from Dr. Applebaum across 25 procedure codes in 2024, for 416 Medicare patients. Medicare paid $315,961 for them.

CMS counts 416 Medicare patients who saw Dr. Applebaum in 2024. The largest group is 65 to 74, with 213 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Applebaum's median patient age at 68, with 61% women.

In 2024, Dr. Applebaum wrote 948 Medicare Part D claims for 450 patients. 85% of them were for generic drugs. CMS names the drug for 851 of them, across 12 drugs with 11 or more claims each, at $40,855 in total drug cost. In 2023, CMS named 813 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Applebaum for performance year 2024, reported as part of a group. Dr. Applebaum accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 145 procedures of melanoma (skin cancer) excision by Dr. Applebaum, more than 96% of the clinicians it reports for that procedure.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Applebaum. Dr. Applebaum's most frequent co-authors are Norberto Mancera, MD and Curtis E. Margo, MD.

CMS Open Payments shows 227 general payments to Dr. Applebaum from 32 drug and device companies from 2017 to 2025. Honoraria make up the largest share, 55% of the total. Horizon Pharma plc paid the most, $25,335.

Dr. Applebaum graduated from University Of Florida College Of Medicine in 2011.

Dr. Applebaum is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.